Dr. Erwin Van Meir is the inaugural David Hart White Endowed Professorship for Brain Cancer Research at the National Cancer Institute-designated O’Neal Comprehensive Cancer Center at the University of Alabama Birmingham.
Dr. Van Meir’s research illuminates how genetic alterations and hypoxia promote tumor formation. He has used this knowledge to create new therapeutics designed to improve quality of life and survival in cancer patients, including the small molecule inhibitors of HIF that OncoSpherix is advancing. He has published over 200 research manuscripts and is co-inventor on over 30 U.S. and international patents.
More information on this honor:
https://www.uab.edu/medicine/news/latest/item/2509-van-meir-appointed-to-inaugural-david-hart-white-endowed-professorship-for-brain-cancer-research